Galapagos NV
GLPG
#5073
Rank
โ‚ฌ1.63 B
Marketcap
24,30ย โ‚ฌ
Share price
0.00%
Change (1 day)
-12.98%
Change (1 year)

EPS for Galapagos NV (GLPG)

EPS in 2026 (TTM): -0,39ย โ‚ฌ

According to Galapagos NV's latest financial reports the company's current EPS (TTM) is -0,36ย โ‚ฌ. In 2025 the company made an earnings per share (EPS) of 5,01ย โ‚ฌ an increase over its 2024 EPS that were of 1,02ย โ‚ฌ.

EPS history for Galapagos NV from 2004 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-0,39ย โ‚ฌ-107.78%
20255,01ย โ‚ฌ390.86%
20241,02ย โ‚ฌ-67.16%
20233,11ย โ‚ฌ-199.64%
2022-3,12ย โ‚ฌ99.03%
2021-1,57ย โ‚ฌ-68.98%
2020-5,06ย โ‚ฌ-298.06%
20192,55ย โ‚ฌ-554.64%
2018-0,56ย โ‚ฌ-77.18%
2017-2,46ย โ‚ฌ-326.21%
20161,09ย โ‚ฌ-134.19%
2015-3,18ย โ‚ฌ-371.34%
20141,17ย โ‚ฌ-445.98%
2013-0,34ย โ‚ฌ32.88%
2012-0,26ย โ‚ฌ-82.07%
2011-1,42ย โ‚ฌ-817.9%
20100,20ย โ‚ฌ12.73%
20090,18ย โ‚ฌ-120.79%
2008-0,85ย โ‚ฌ-37.67%
2007-1,36ย โ‚ฌ39.64%
2006-0,97ย โ‚ฌ28.17%
2005-0,76ย โ‚ฌ6.25%
2004-0,71ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
7,65ย โ‚ฌ-2,244.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
3,16ย โ‚ฌ-985.84%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
1,80ย โ‚ฌ-604.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
2,24ย โ‚ฌ-728.35%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
3,13ย โ‚ฌ-977.57%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
6,09ย โ‚ฌ-1,806.09%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
3,41ย โ‚ฌ-1,054.01%๐Ÿ‡ฌ๐Ÿ‡ง UK
Fortress Biotech
FBIO
3,15ย โ‚ฌ-981.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
1,20ย โ‚ฌ-436.31%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel